quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:27·38d
SECFiling
CytomX Therapeutics Inc. logo

SEC Form 10-K filed by CytomX Therapeutics Inc.

CTMX· CytomX Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CTMX
    CytomX Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 16UpdateAnalyst$12.00
  • Jan 20UpdateGuggenheim$10.00
  • Sep 22UpdateCantor Fitzgerald$6.00
  • Sep 17UpdateBarclays$3.50
  • Jul 31UpdateOppenheimer$7.00
  • May 15UpdateH.C. Wainwright$5.00

Related

  • SEC3d
    SEC Form PRE 14A filed by CytomX Therapeutics Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by CytomX Therapeutics Inc.
  • INSIDER35d
    SEC Form 4 filed by Chu Yu-Waye
  • INSIDER35d
    SEC Form 4 filed by Mccarthy Sean A.
  • INSIDER35d
    SEC Form 4 filed by Belvin Marcia
  • INSIDER35d
    SEC Form 4 filed by Ogden Christopher
  • SEC35d
    SEC Form 8-K filed by CytomX Therapeutics Inc.
  • SEC36d
    SEC Form 424B5 filed by CytomX Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022